Coronavirus: US drug authority set to meet next month to discuss COVID-19 vaccine

Published: Updated:
Read Mode
100% Font Size
1 min read

A Food and Drug Administration advisory committee is set to meet on December 10 to discuss Pfizer Inc.’s request for an emergency use authorization for its developing COVID-19 vaccine.

Pfizer and its German partner BioNTech recently announced that the vaccine appears 95 percent effective at preventing mild to severe COVID-19 disease in a large, ongoing study.

Dr. Moncef Slaoui, head of the Operation Warp Speed, the coronavirus vaccine program, says plans are to ship vaccines to states within 24 hours of expected FDA approval.

Visit our dedicated coronavirus site here for all the latest updates.

Slaoui told CNN he expects vaccinations would begin on the second day after approval, December 12.

Read more:

Coronavirus: Moderna to charge $25-$37 for COVID-19 vaccine, CEO says

G20 leaders pledge to fund fair distribution of COVID-19 vaccines, says draft statement

Russia's Putin in G20: Ready to provide our coronavirus vaccine to countries in need

Top Content Trending